Aura Biosciences (AURA) Competitors $5.52 -0.24 (-4.17%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$5.52 0.00 (0.00%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AURA vs. AMPH, ARDX, DYN, AUPH, SNDX, BGM, ADPT, IOVA, WVE, and ETNBShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Amphastar Pharmaceuticals (AMPH), Ardelyx (ARDX), Dyne Therapeutics (DYN), Aurinia Pharmaceuticals (AUPH), Syndax Pharmaceuticals (SNDX), Qilian International Holding Group (BGM), Adaptive Biotechnologies (ADPT), Iovance Biotherapeutics (IOVA), Wave Life Sciences (WVE), and 89bio (ETNB). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Amphastar Pharmaceuticals Ardelyx Dyne Therapeutics Aurinia Pharmaceuticals Syndax Pharmaceuticals Qilian International Holding Group Adaptive Biotechnologies Iovance Biotherapeutics Wave Life Sciences 89bio Amphastar Pharmaceuticals (NASDAQ:AMPH) and Aura Biosciences (NASDAQ:AURA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations. Which has stronger valuation and earnings, AMPH or AURA? Amphastar Pharmaceuticals has higher revenue and earnings than Aura Biosciences. Aura Biosciences is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmphastar Pharmaceuticals$731.97M1.56$137.54M$3.067.87Aura BiosciencesN/AN/A-$76.41M-$1.75-3.15 Does the media prefer AMPH or AURA? In the previous week, Amphastar Pharmaceuticals had 2 more articles in the media than Aura Biosciences. MarketBeat recorded 8 mentions for Amphastar Pharmaceuticals and 6 mentions for Aura Biosciences. Aura Biosciences' average media sentiment score of 1.29 beat Amphastar Pharmaceuticals' score of 0.88 indicating that Aura Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amphastar Pharmaceuticals 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Aura Biosciences 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer AMPH or AURA? Amphastar Pharmaceuticals received 366 more outperform votes than Aura Biosciences when rated by MarketBeat users. Likewise, 65.88% of users gave Amphastar Pharmaceuticals an outperform vote while only 61.90% of users gave Aura Biosciences an outperform vote. CompanyUnderperformOutperformAmphastar PharmaceuticalsOutperform Votes39265.88% Underperform Votes20334.12% Aura BiosciencesOutperform Votes2661.90% Underperform Votes1638.10% Is AMPH or AURA more profitable? Amphastar Pharmaceuticals has a net margin of 21.80% compared to Aura Biosciences' net margin of 0.00%. Amphastar Pharmaceuticals' return on equity of 26.44% beat Aura Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Amphastar Pharmaceuticals21.80% 26.44% 11.89% Aura Biosciences N/A -41.57%-36.43% Do institutionals and insiders believe in AMPH or AURA? 65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. Comparatively, 96.8% of Aura Biosciences shares are held by institutional investors. 27.1% of Amphastar Pharmaceuticals shares are held by insiders. Comparatively, 5.4% of Aura Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate AMPH or AURA? Amphastar Pharmaceuticals currently has a consensus price target of $43.50, suggesting a potential upside of 80.72%. Aura Biosciences has a consensus price target of $22.75, suggesting a potential upside of 312.14%. Given Aura Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Aura Biosciences is more favorable than Amphastar Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amphastar Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has more volatility & risk, AMPH or AURA? Amphastar Pharmaceuticals has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Aura Biosciences has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. SummaryAmphastar Pharmaceuticals beats Aura Biosciences on 12 of the 18 factors compared between the two stocks. Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$277.24M$2.93B$5.40B$7.70BDividend YieldN/A1.91%5.44%4.32%P/E Ratio-3.1930.4322.1918.31Price / SalesN/A478.74401.66107.05Price / CashN/A168.6838.2034.62Price / Book1.213.786.854.25Net Income-$76.41M-$72.06M$3.20B$247.51M7 Day Performance2.99%11.17%5.91%6.33%1 Month Performance-22.03%-4.87%-4.20%-3.33%1 Year Performance-22.03%-18.74%18.07%5.15% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences2.3304 of 5 stars$5.52-4.2%$22.75+312.1%-22.3%$277.24MN/A-3.1950Positive NewsAMPHAmphastar Pharmaceuticals4.378 of 5 stars$23.50+0.6%$43.50+85.1%-41.3%$1.12B$731.97M7.831,620Positive NewsARDXArdelyx4.2692 of 5 stars$4.56-5.4%$10.61+132.7%-21.9%$1.09B$333.62M-28.5090Upcoming EarningsNews CoverageDYNDyne Therapeutics3.5427 of 5 stars$9.33+14.2%$47.46+408.7%-55.5%$1.06BN/A-2.62100Upcoming EarningsHigh Trading VolumeAUPHAurinia Pharmaceuticals2.5604 of 5 stars$7.66-1.2%$11.50+50.1%+61.0%$1.05B$235.13M-51.06300Upcoming EarningsNews CoveragePositive NewsSNDXSyndax Pharmaceuticals3.4726 of 5 stars$11.93+3.4%$36.20+203.4%-36.0%$1.03B$23.68M-3.29110Positive NewsGap UpBGMQilian International Holding GroupN/A$10.52-4.4%N/AN/A$1.02B$25.10M0.00298ADPTAdaptive Biotechnologies3.2858 of 5 stars$6.83-6.8%$9.40+37.6%+203.5%$1.01B$178.96M-6.27790Upcoming EarningsPositive NewsIOVAIovance Biotherapeutics4.2173 of 5 stars$3.08+0.7%$18.22+491.6%-71.3%$1.01B$164.07M-2.07500WVEWave Life Sciences4.3329 of 5 stars$6.12+3.4%$22.18+262.4%+35.5%$939.33M$108.30M-5.51240Positive NewsETNB89bio2.9722 of 5 stars$6.27+3.5%$27.56+339.5%-19.6%$915.32MN/A-2.1540Analyst ForecastOptions VolumeGap Down Related Companies and Tools Related Companies Amphastar Pharmaceuticals Competitors Ardelyx Competitors Dyne Therapeutics Competitors Aurinia Pharmaceuticals Competitors Syndax Pharmaceuticals Competitors Qilian International Holding Group Competitors Adaptive Biotechnologies Competitors Iovance Biotherapeutics Competitors Wave Life Sciences Competitors 89bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AURA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AURA Stock Free AURA Stock Alerts